Literature DB >> 1172422

The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats.

J Sarnek, L Baran.   

Abstract

The influence of factors which inhibit 5-hydoxytryptamine (5-HT) synthesis, i.e. p-chlorophenylalanine (PCPA) and p-chloroamphetamine (PCA), on cataleptic action of the neuroleptics: spiroperiodol, pimozide, reserpine and fluphenazine was studied. PCPA showed weak anticataleptic activity in reserpine-induced catalepsy but had no effect on catalepsy induced by spiroperidol or fluphenazine. PCPA also tended to depress the cataleptic effect of pimozide, but the results were not statistically significant. PCA had no influence on catalepsy induced by neuroleptics from the group of butyrophenones, potentiated the cataleptic action of reserpine in the dose of 5 mg/kg, and suppressed catalepsy induced by reserpine in the dose of 10 mg/kg. The results suggest that under conditions of the inhibition of the inhibition of 5-HT synthesis the cataleptic action of some neuroleptics may be slightly modified.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1172422

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  3 in total

Review 1.  Biochemical and behavioural properties of clozapine.

Authors:  D M Coward; A Imperato; S Urwyler; T G White
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.

Authors:  H L Andersen; I C Kilpatrick
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

3.  Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine.

Authors:  C L Broekkamp; S K Oosterloo; H H Berendsen; A M van Delft
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.